share_log

Stifel Maintains Buy on RxSight, Lowers Price Target to $70

Stifel Maintains Buy on RxSight, Lowers Price Target to $70

斯蒂费尔继续买入RxSight,将目标价下调至70美元。
Benzinga ·  07/10 09:25

Stifel analyst Thomas Stephan maintains RxSight (NASDAQ:RXST) with a Buy and lowers the price target from $75 to $70.

Stifel分析师Thomas Stephan认为RxSight(纳斯达克代码:RXST)值得买入,并将价格目标从75美元调低至70美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发